Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

This study aims to compare several different treatments that may be useful for patients with COVID-19 and/or influenza pneumonia. These treatments have been recommended for testing by the expert panel that advises the Chief Medical Officer in England. Although these treatments show promise, nobody knows if any of them will help patients recover more effectively than the usual standard of care all patients at your hospital will receive. 

The treatments for COVID-19which may be given in addition to the usual care at your hospital, include a a high dose steroid, dexamethasone (if you have low oxygen levels), or a treatment for diabetes or heart failure called empagliflozin, a synthetic antibody treatment directed against the virus (called sotrovimab) and an antiviral drug called molnupiravir 

The treatments for influenza pneumoniawhich may be given on top of your usual care, include two anti-viral treatments, oseltamivir and baloxavir and low-dose dexamethasone. At present, we don’t know whether any of these will work. However, the side-effects are already well-known from other uses and so your doctor will be able to monitor you appropriately.